نتایج جستجو برای: revised international staging system r iss

تعداد نتایج: 2887717  

2010
S. Diederich

Staging systems aim to describe malignant tumours in a standardized fashion to assist in therapy planning and estimation of prognosis, allow comparison of different therapeutic strategies, facilitate communication between individuals and institutions, improve our knowledge of malignant disease and ultimately improve the outcome for patients. With the continuous increase in data and, ideally, ou...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014
Marco A Ramírez-Ortiz M Veronica Ponce-Castañeda M Lourdes Cabrera-Muñoz Aurora Medina-Sansón Xinhua Liu Manuela A Orjuela

BACKGROUND More invasive retinoblastoma, characterized by increased morbidity and mortality, with lower rates of eye salvage and higher rates of extraocular dissemination, seems more prevalent in resource-poor countries. The relationship of diagnostic delay (lag time) and sociodemographic factors on the extent of disease at diagnosis has not been examined separately for unilateral and bilateral...

Journal: :Resuscitation 2021

Clinical staging of accidental hypothermia is used to guide out-of-hospital treatment and transport decisions. Most clinical systems utilize core temperature, by measurement or estimation, stage hypothermia, despite the challenge obtaining accurate field measurements. Recent studies have demonstrated that estimation temperature imprecise.We propose a revision original Swiss Staging system. The ...

Journal: :European Journal of Cancer Care 2023

Objective. Multiple myeloma (MM) represents a malignant tumor with abnormal proliferation of plasma cells. The current study sought to investigate the changes in serum lncRNA MIR17HG (long noncoding RNA miR-17-92a-1 cluster host gene) levels MM patients and its values assessing accuracy diagnosis predicting diagnosis. Methods. First, 108MM 85 healthy controls were enrolled as subjects. all subj...

Journal: :Journal of Ayub Medical College, Abbottabad : JAMC 2014
Abdul Basit Neelam Siddiqui Abdul Hameed Narjis Muzaffar Sohail Athar

BACKGROUND Multiple myeloma is a heterogeneous disease, with wide survival range and multiple risk factors and staging systems linked to survival. The objective of this study was to assess the overall survival of patients with multiple myeloma (MM) diagnosed and treated at Shaukat Khanum Memorial Cancer Hospital (SKMCH), Lahore with respect to various prognostic factors. METHODS This was a su...

2014
J Lu J Lu W Chen Y Huo X Huang J Hou

The aim of this study was to understand the clinical features and treatment outcome of Chinese patients with multiple myeloma (MM). This retrospective study enrolled 940 newly diagnosed inpatients (median age, 59 years; immunoglobulin (Ig)D isotype, 6.5%) with complete follow-up data at three centers. In all, 85.8% of patients were of Durie-Salmon stage III and 48.3% were of International Stagi...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2005
L A Moulopoulos D Gika A Anagnostopoulos K Delasalle D Weber R Alexanian M A Dimopoulos

BACKGROUND Magnetic resonance imaging (MRI) has been a useful technique for the assessment of patients with multiple myeloma (MM). We evaluated the prognostic significance of different MRI patterns in symptomatic patients with MM. PATIENTS AND METHODS A total of 142 symptomatic MM patients underwent MRI before treatment. MRI patterns of involvement were correlated with known prognostic variab...

Journal: :British journal of haematology 2016
Artur Jurczyszyn Hareth Nahi Irit Avivi Alessandro Gozzetti Ruben Niesvizky Sujitha Yadlapati David S Jayabalan Paweł Robak Tomas Pika Kristian T Andersen Leo Rasche Krzysztof Mądry Dariusz Woszczyk Małgorzata Raźny Lidia Usnarska-Zubkiewicz Wanda Knopińska-Posłuszny Małgorzata Wojciechowska Renata Guzicka-Kazimierczak Monika Joks Sebastian Grosicki Hanna Ciepłuch Marcin Rymko David H Vesole Jorge J Castillo

We compared the outcomes of multiple myeloma (MM) patients aged 21-40 and 41-60 years in the novel agent era. This case-control study included 1089 patients between 2000 and 2015. Cases and controls were matched for sex, International Staging System (ISS) stage and institution. There were 173 patients in the younger group and 916 patients in the older group. Younger patients presented with a hi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید